Company Filing History:
Years Active: 2003-2014
Title: Innovations of Bruno Pot in Probiotic Bacteria
Introduction
Bruno Pot is an accomplished inventor based in Sint Michiels Brugge, Belgium. He has made significant contributions to the field of microbiology, particularly in the development of probiotic compositions. With a total of two patents to his name, Pot's work focuses on the application of beneficial bacteria in food products and medical treatments.
Latest Patents
Bruno Pot's latest patents include innovations related to bifidobacterial species and lactic acid bacteria. His first patent describes a new bacterium, GC61, belonging to the genus of bifidobacteria. This bacterium is utilized in probiotic compositions, particularly in food products, and has potential applications in treating gastrointestinal diseases. The second patent involves a strain of lactic acid bacterium characterized by its unique 16S ribosomal RNA and total protein profile. This strain is distinct from recognized species of the genus Streptococcus and is intended for use in dietary compositions, such as acidified milk or fromage frais.
Career Highlights
Throughout his career, Bruno Pot has worked with prestigious institutions, including the University of Liège and the Institut Pasteur de Lille. His research has focused on the health benefits of probiotics and their applications in food science and medicine. Pot's innovative work has contributed to the understanding of how specific bacterial strains can improve human health.
Collaborations
Bruno Pot has collaborated with notable colleagues in his field, including Georges Daube and Christine Franssen. These partnerships have facilitated advancements in probiotic research and the development of new dietary compositions.
Conclusion
Bruno Pot's contributions to the field of probiotics through his patents and collaborations highlight the importance of beneficial bacteria in health and nutrition. His work continues to influence the development of innovative food products and medical treatments.